The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of anti-CD3 x anti-EGFR–armed activated T-cells for treatment of advanced colorectal or pancreatic cancer.
 
Minsig Choi
Honoraria - Bayer/Onyx
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Celgene
Research Funding - Merck
 
Greg Dyson
No Relationships to Disclose
 
Archana Thakur
No Relationships to Disclose
 
Hemchandra Mahaseth
No Relationships to Disclose
 
Philip Agop Philip
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Novartis; Roche; Sanofi
Consulting or Advisory Role - Bayer; Celgene; epson; Lilly; novartis; Roche
Speakers' Bureau - Amgen; Bayer; Celgene; roche; sanofi
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Roche (Inst)
 
Anthony Frank Shields
No Relationships to Disclose
 
Abhinav Deol
No Relationships to Disclose
 
Lawrence G. Lum
Stock and Other Ownership Interests - TransTarget
Research Funding - Dendreon
Patents, Royalties, Other Intellectual Property - TransTarget